Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Markforged Holding CorpAONE.U · Entity 80484 | Director | August 17, 2020 | August 19, 2020 |
| Quince Therapeutics, Inc.CRTX · Entity 7403 | 10% owner | May 13, 2019 | May 13, 2019 |
| twoTWOA · Entity 92527 | Director | March 29, 2021 | March 29, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Markforged Holding Corp
Report date August 17, 2020 · Filed August 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Ordinary SharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-08-17 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares will automatically convert into Class A ordinary shares at the time of the Issuer's initial business combination. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares will automatically convert into Class A ordinary shares at the time of the Issuer's initial business combination.
Quince Therapeutics, Inc.
Report date May 13, 2019 · Filed May 13, 2019
Jointly reported with Lamond Christine
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019 | 962,510 |
Reported balance
After 2019-05-13 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2019-05-13 · Conversion · Acquired 962,510 · Balance 962,510 F1: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock. F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F3: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. |
| Common StockSEC Table I · non-derivative | IndirectBy Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019 | 962,510 |
Reported balance
After 2019-05-13 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2019-05-13 · Conversion · Acquired 962,510 · Balance 962,510 F1: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock. F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F4: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. |
| Common StockSEC Table I · non-derivative | IndirectBy Pierre R. and Christine E. Lamond Trust 11-22-85 | 961,510 |
Reported balance
After 2019-05-13 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2019-05-13 · Conversion · Acquired 961,510 · Balance 961,510 F1: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock. F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F5: Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85. |
| Series A Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019 | 0 |
Reported balance
After 2019-05-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-05-13 · Conversion · Disposed 500,483 · Balance 0 F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F3: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. |
| Series A Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019 | 0 |
Reported balance
After 2019-05-13 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-05-13 · Conversion · Disposed 500,482 · Balance 0 F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F4: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. |
| Series A Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy Pierre R. and Christine E. Lamond Trust 11-22-85 | 0 |
Reported balance
After 2019-05-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-05-13 · Conversion · Disposed 961,510 · Balance 0 F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F5: Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85. |
| Series B Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019 | 0 |
Reported balance
After 2019-05-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-05-13 · Conversion · Disposed 462,027 · Balance 0 F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F3: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. |
| Series B Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectBy Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019 | 0 |
Reported balance
After 2019-05-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-05-13 · Conversion · Disposed 462,028 · Balance 0 F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F4: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock.
F2: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
F3: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019.
F4: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019.
F5: Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85.
two
Report date March 29, 2021 · Filed March 29, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-03-29 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253802) under the heading "Description of Securities-Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. Includes 750,000 Class B ordinary shares that are subject to forfeiture if the underwriter of the issuer's initial public offering does not exercise in full its option to purchase additional Class A ordinary shares. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253802) under the heading "Description of Securities-Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. Includes 750,000 Class B ordinary shares that are subject to forfeiture if the underwriter of the issuer's initial public offering does not exercise in full its option to purchase additional Class A ordinary shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionSeries B Redeemable Convertible Preferred Stock · Derivative | 462,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · derivative · entry 8 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019 Disclosed balance after: 0 Underlying: Common Stock · 462,028 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F4 · ownership.nature: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionSeries B Redeemable Convertible Preferred Stock · Derivative | 462,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · derivative · entry 7 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019 Disclosed balance after: 0 Underlying: Common Stock · 462,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 961,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · derivative · entry 6 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pierre R. and Christine E. Lamond Trust 11-22-85 Disclosed balance after: 0 Underlying: Common Stock · 961,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F5 · ownership.nature: Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 500,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · derivative · entry 5 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019 Disclosed balance after: 0 Underlying: Common Stock · 500,482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F4 · ownership.nature: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 500,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · derivative · entry 4 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019 Disclosed balance after: 0 Underlying: Common Stock · 500,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionCommon Stock | 961,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · nonDerivative · entry 3 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pierre R. and Christine E. Lamond Trust 11-22-85 Disclosed balance after: 961,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock. F2 · price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F5 · ownership.nature: Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionCommon Stock | 962,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · nonDerivative · entry 2 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019 Disclosed balance after: 962,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock. F2 · price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F4 · ownership.nature: Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019. Read SEC document |
| May 13, 2019 Filed May 13, 2019 19:50 UTC | Quince Therapeutics, Inc. CRTX · Entity 7403 | ConversionCommon Stock | 962,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-029477 · doc4.xml · nonDerivative · entry 1 LAMOND PIERRE · CIK 0001190683 · 10% owner Lamond Christine · CIK 0001775830 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019 Disclosed balance after: 962,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock. F2 · price: Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.